Lushang Freda Pharmaceutical financials at a glance

+ Portfolio

The revenue of Lushang Freda Pharmaceutical is reported as 4.57875 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.14 Yuan Renminbi per share in 2023, which was 133.33 higher than 2022. And about 0.26278 billion Yuan Renminbi are reported as free cash flow in the financials of Lushang Freda Pharmaceutical 2023. Dividends of 0.1 Yuan Renminbi per share were paid to shareholders of Lushang Freda Pharmaceutical stock SHSE:600223 in fiscal 2023.

¥4.58B

Revenue

¥0.14

Earnings Per Share

46.33%

Gross Margin %

¥5.25B

Free Cash Flow

Revenue

4,578.75

Earnings Per Share

0.14

Gross Margin %

46.33

Free Cash Flow

5,248.00

Financials

Year	Year	TTM	2023	2022	2020	2015	2013	2012	2011	2010
Rev.	Revenue	N/A	¥4.58B	¥12.95B	¥13.62B	¥5.86B	¥5.29B	¥3.67B	¥2.38B	¥3.02B
GM %	Gross Margin %	29.42%	46.33%	22.59%	20.27%	19.71%	28.21%	29.93%	27.16%	33.86%
OM	Operating Margin	3.22%	4.97%	4.44%	5.63%	4.73%	10.15%	13.01%	12.57%	20.38%
EPS	Earnings Per Share	¥0.11	¥0.14	¥0.06	¥0.62	¥0.13	¥0.26	¥0.25	¥0.22	¥0.46
Div.	Dividends	N/A	¥0.10	¥0.07	¥0.00	¥0.00	¥0.15	¥0.00	¥0.00	¥0.06
PR %	Payout Ratio %	0	71.43%	116.67%	0	0	57.69%	0.00%	0.00%	13.04%
Sha.	Shares	N/AM	1,016.57M	1,016.57M	1,009.15M	1,000.97M	1,000.97M	1,000.97M	1,000.97M	1,000.97M
OCF	Operating Cash Flow	N/A	¥474.15M	¥998.10M	¥4.45B	¥-1,797.51M	¥-1,087.85M	¥0.00M	¥-3,633.91M	¥-1,464.83M
FCF	Free Cash Flow	N/A	¥5.25B	¥837.68M	¥4.29B	¥-1,812.39M	¥-1,102.01M	¥0.00M	¥-3,654.59M	¥-1,472.08M
FCFS	Free Cash Flow Per Share	¥-0.11	¥0.26	¥0.73	¥4.30	¥-1.77	¥-1.09	¥-0.09	¥-3.65	¥-1.47

Lushang Freda Pharmaceutical financials at a glance

Financials

Discover